Idexx Laboratories (IDXX) has a PEG ratio of 277.47, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow277.47
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for IDXX is 277.47. That is above the Healthcare sector average of 11.64. Investors often review this figure alongside Idexx Laboratories's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, IDXX currently prints 277.47 for PEG ratio, while the sector average sits near 11.64. That is roughly 2283.6% above the sector mean. Large gaps often invite a closer look at Idexx Laboratories's growth, margins, and balance sheet.
A PEG ratio of 277.47 for Idexx Laboratories is not 'good' or 'bad' on its own. Compare it with the peer average (11.64) and with IDXX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting IDXX's PEG ratio (277.47), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Idexx Laboratories's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.